Advertising Age - Life afterJack: The unlikely tale of Hill Holliday’s comeback.(News)
Friday, October 31st, 2008 Byline: RUPAL PAREKH And MATTHEW CREAMER
rparekh@adage.com, mcreamer@adage.com
Related Results
…
Byline: RUPAL PAREKH And MATTHEW CREAMER
rparekh@adage.com, mcreamer@adage.com
Related Results
…
Results have been published in The Lancet from the eagerly-awaited VALUE (Valsartan Antihypertensive Long-term Use Evaluation) trial, which compared Novartis’ angiotensin II receptor blocker Diovan (valsartan) with Pfizer’s calcium antagonist Norvasc (amlodipine) in hypertensive patients at high cardiovascular risk.
Most Popular
3 Questions No Job Seeker Ever Wants T…
Two new studies have produced mixed results for two different drugs that are often used to treat heart failure.
In the first study, researchers found limited benefit from a drug called valsartan (Diovan), which is used to lower systolic bloo…
(valsartan, Novartis)
An angiotensin receptor blocker (ARB) for treating heart failure (New York Heart Association class II-IV) in people who cannot tolerate ACE inhibitors. The first ARB approved for heart fa…
Diovan lowered the level of the inflammatory
marker high sensitivity C-reactive protein (hsCRP), independently of its
established efficacy in lowering blood pressure, according to findings
presented at the American Society of Hypertension, Inc. (ASH) Annual
Scientific Meeting and Exposition (ASH 2006) and published online in
Hypertension later today. The study also showed that Diovan and Diovan HCT
helped a significant number of hard-to-treat patients with a severe for…
Generic Diovan Valsartan is used for:
Treating high blood pressure alone or with other medicines. It is also used for treating heart failure in patients who do not tolerate angiotensin-converting enzyme (ACE) inhibitors.
Ge…
NEW ORLEANS, LA, Nov 15, 2000
Most Popular
Eight Major Job Trends For 2008
3 Questions No Job Seeker Ever Wants To Be Asked?
Today’s Best Part-Time Jobs
Five Ways To Successfully Negotiate A Salary
5 Regular Mistakes In Public Speaking
On the basis of new data from the largest clinical study of its kind, Novartis is to seek worldwide approvals for its selective angiotensin II receptor b…
Data were presented at the annual meeting of the American Heart Association, in Orlando, Florida, showing that Novartis’ Diovan (valsartan) is as effective as the angiotensin-converting enzyme inhibitor captopril in patients who are at high risk for cardiovascular events after myocardial infarction.
Most Popular
10 Jobs Tha…